The short version
27 companies supply this market — deep enough that no single failure threatens the supply.
Market view
oxaliplatin
63 marketed package NDCs · 27 active manufacturers
Most dispensed: 5 mg/mL · Injection, Solution · #1 vial/carton / 10 ml in 1 vial · 5 mg/mL · Injection, Solution · #1 vial/carton / 20 ml in 1 vial · 5 mg/mL · Injection, Solution · #1 vial, single-dose/carton / 10 ml in 1 vial, single-dose · 5 mg/mL · Injection, Solution · #1 vial, single-dose/carton / 20 ml in 1 vial, single-dose
Same drug class
Other molecules FDA puts in Platinum-based Drug, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Common questions
- Is Oxaliplatin in shortage right now?
- No. FDA does not currently list Oxaliplatin in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Oxaliplatin?
- 27 companies have marketed Oxaliplatin in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.